Nephrocare Health Services Limited IPO
Nephrocare Health Services Limited IPO
Nephrocare Health Services Limited IPO
₹ 14720 / 32 Shares Shares
Minimum Investment
Nephrocare Health Services Limited IPO
Issues Price
₹438-460 per equity share
Nephrocare Health Services Limited IPO
Open Date
10 Dec 2025
Close Date
12 Dec 2025
Lot Size
16
Min. Investment
₹ 14720
Issue Price
₹438-460
Listing Date
17 Dec 2025
Issues Size
1,89,35,819 shares(aggregating up to ₹871.05 crore)
Face Value
₹2 Per Equity Share
Total Shares Offered
32 Shares
Offered To Public
32 Shares
Nephrocare Health Services Limited IPO
Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide network of clinics across India and select international markets. It offers services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of March 31, 2025, Nephrocare operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 269 cities in 21 States and four Union Territories. Approximately 76.73% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions. In Fiscal 2025, Nephrocare treated 29,281 patients and performed more than 2.88 million dialysis treatments, amounting to approximately 10% of the country's total dialysis patient base. The number of dialysis machines operated by the company increased to 5,068 as of March 2025 from 4,714 in Fiscal 2024 and 3,662 in Fiscal 2023. Nephrocare has formulated strategic alliances with leading hospital chains like Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers. As of March 2025, the workforce consisted of 3,230 employees, including both medical and administrative staff working across its clinics and corporate office.
Founded In
2010
Managing Director
Vikram Vuppala
Parent Organization
Nephrocare Health Services Limited IPO
Application for Nephrocare Health Services Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹438-460 | ₹14,720 |
| Retail(max) | ₹438-460 | ₹1,91,360 |
| SHNI(min) | ₹438-460 | ₹2,06,080 |
| SHNI(max) | ₹438-460 | ₹9,86,240 |
| BHNI(min) | ₹438-460 | ₹10,00,960 |
Apply for all eligible candidates, Nephrocare Health Services Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare made it easy to access funds against my mutual investments. The process was fast, smooth, and completely transparent.
Living overseas, I struggled with Indian investments. KSquare’s NRI Corner fixed that. Their expert advice and ease of access gave me complete peace of mind.
I loved how simple KSquare made the entire loan procedure. No delays, no confusion—just straight financial help.
KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.
KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.
KSquare’s approach to New Fund Offerings really impressed me. I finally feel confident participating in something I once thought was too complicated.
KSquare makes it simple to understand which NFO suits you. Their comparisons and insights saved me hours of research. Totally recommend it!
KSquare helped me plan my retirement with complete clarity. The SIP guidance was simple, personalised, and stress-free. I now feel financially confident about my future and family responsibilities.
KSquare really simplified the NPS process for me. I appreciate their educational approach and helpful customer support.
KSquare gave me confidence to grow wealth in India from abroad. The onboarding was smooth, and they guided me at every step.
FAQ's
Frequenlty Asked Question
Why should I invest in mutual funds through KSquare?
KSquare offers expert-curated fund options, personalized recommendations, and a user-friendly platform to simplify mutual fund investing.
What is the minimum investment for NPS?
You can start your NPS investment with as little as ₹500 for Tier I and ₹1,000 for Tier II accounts.
Is there a lock-in period for mutual fund investments?
Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.
How do I choose the right asset allocation in NPS?
KSquare helps you select between Active and Auto choices based on your age, risk appetite, and retirement goals.
Can I cancel or modify my NFO investment once submitted?
Yes, you can cancel or modify your NFO investment only before the allotment is processed and while the NFO is still open. Once the NFO closes and units are allotted, the investment cannot be changed or cancelled. After allotment, you may exit only through redemption, as per applicable terms and conditions.
Can I change my fund manager in NPS via KSquare?
Yes, KSquare allows you to switch your fund manager or investment option once a year through your dashboard.
Will I still earn returns on pledged mutual funds?
Yes, your mutual fund units continue to generate returns even while they are pledged for a loan.
What is the role of the AMC in a New Fund Offering?
The Asset Management Company (AMC) designs and manages the NFO, ensuring strategy alignment and regulatory compliance.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.